We recently visited the remains of Edward McGehee’s once-grand home, Bowling Green Plantation, located in Woodville, Mississippi. While there, we documented a cemetery tour of the McGehee family ...

WOODVILLE, Ala. (WAFF) - A historic chapel in Woodville faces demolition after officials say it poses a safety hazard. In honor of Good Friday, we share the story of Woodville Methodist Chapel, which ...

STARKVILLE — Mississippi State baseball has won six of its past seven games, making the NCAA tournament appear like more of a possibility. After falling to South Carolina on April 4 for a 1-9 ...

The Mississippi River is considered the most endangered in the U.S. due to uncertainty over the Federal Emergency Management Agency's future, according to an environmental group based in ...

Maria Sandoval leans on a handmade cross bearing the names of loved ones passed as she waits in line to visit El Santuario De Chimayo in Northern New Mexico on Good Friday, April 18, 2025. Chimayo ...

The Department of Justice (DOJ) released documents Wednesday demonstrating Kilmar Armando Abrego Garcia’s membership in the MS-13 gang. Abrego Garcia’s police interview, immigration court ...

Want some free Desert Detectors rewards without having to dig a single hole? Lucky for you, we've compiled all of the free redeemable codes currently active in Roblox's popular digging simulator ...

Online Mississippi sports betting takes a step forward: Local bettors can now download MS sportsbook apps from top betting sites, including BetMGM, within state lines and place online wagers from ...

This evening will be cloudy with lingering patchy rain at first. Turning dry and largely clear overnight with just a few patches of cloud. Tuesday Tomorrow morning will be largely dry and bright ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).